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Structure optimisation and biological
evaluation of bone scaffolds prepared by
co-sintering of silicate and phosphate glasses
G. Novajra1, P. Perdika1, R. Pisano1, M. Miola1, A. Bari1, J. R. Jones2, R. Detsch3,
A. R. Boccaccini3 and C. Vitale-Brovarone*1
A degradable phosphate glass (ICEL) and a bioactive silicate glass (CEL2) were mixed in
different ratios (wt-%: 100%ICEL, 70%ICEL–30%CEL2, 30%ICEL–70%CEL2, 100%CEL2; codes
100-0, 70-30, 30-70, 0-100) and then co-sintered to obtain three-dimensional porous scaffolds by
gel casting foaming. Thermal analyses were carried out on the glass mixtures and were used as a
starting point for the optimisation of the scaffold sintering treatment. The microcomputed
tomography and field emission scanning electron microscope analyses allowed the selection of
the optimal sintering temperature to obtain an adequate structure in terms of total and open
porosity. The scaffolds showed an increasing solubility with increasing ICEL glass content, and for
30-70 and 0-100, the precipitation of hydroxyapatite in simulated body fluid was observed. In vitro
tests indicated that all the scaffolds showed no cytotoxic effect. The co-sintering of silicate and
phosphate glasses showed to be a promising strategy to tailor the scaffold osteoconductivity,
degradation and bioactivity.
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Introduction
Bone tissue engineering aims to use three-dimensional
(3-D) porous materials (i.e. scaffolds) to support and
stimulate the regeneration of injured bone as an alterna-
tive to the use of autograft (the current gold standard).
Scaffolds have to meet specific requirements in terms of
morphological features and mechanical properties. The
scaffold should elicit an adequate biological response
without any cytotoxic effect due to the material or its
degradation products; for degradable materials, the
degradation rate has to be carefully tailored in order to
match that of the regenerating tissue.1 The scaffold
structure should have an interconnected porosity (40–70
vol.-%) for tissue ingrowth and vascularisation,minimum
pore size of 100 mm for cell migration andw200–300 mm
for the enhancement of direct bone formation and new
vessel formation.2 All this features have a great influence
on the mechanical properties of the scaffold, which
should provide adequate mechanical stability, especially
in the first phase of the bone regeneration process.
Glasses have been widely studied for bone applications
sinceHench and co-workers3 developed the first bioactive
glass, called BioglassH. Silica based bioactive glasses are
able to firmly bond to both hard and soft tissue by the
precipitation of hydroxycarbonate apatite (HCA)
(i.e. the mineral phase of natural bone) on their surface
when put in contact with physiological fluids; moreover,
ion release from these glasses induces the
up-regulations of genes in osteoprogenitor cells,
enhancing bone regeneration.4 Phosphate glasses have
also been proposed for the fabrication of degradable bone
scaffolds5–7 due to their solubility in aqueous media,
which is strongly influenced by the glass composition.
In this work, powders of a degradable phosphate glass
(ICEL)8,9 and of a bioactive silicate glass (CEL2),9,10 both
developed at Politecnico di Torino, were co-sintered to
obtain 3-D porous scaffolds with tailored bioactivity and
degradation. The co-sintering of glasses deriving from
different forming oxides (i.e. SiO2 andP2O5) is expected to
impart to the obtained material a combination of the
properties of the two glasses, that is, the degradation of
the phosphate based glass and of its derived crystalline
phases and the bioactivity of the silica based glass. The
ratio between the two glasses is also expected to influence
the predominance of one property over the other, thus
allowing to obtain scaffolds with very different properties
while using the same starting materials.
Using glass powder as the starting material, glass–
ceramics porous scaffolds can be produced with different
techniques aiming to reach a high volume of open
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macroporosity. In this context, some techniques can be
mentioned such as the burn-out of a porogen,11 sponge
replication,10,12 freeze casting,13 H2O2 foaming
14 and gel
cast foaming technique.15,16 In this work, the gel cast
foaming technique was used in combination with freeze
drying and the authors focused their work on
the optimisation of the scaffold structure and on the
characterisation of the optimised scaffolds. In particular,
the analysis of the phase composition and preliminary
tests on the scaffold bioactivity, dissolution and bio-
compatibility to investigate the influence of the different
ICEL/CEL2 ratios on the final scaffold properties were
carried out. After the optimisation of the scaffold
structure and the maximisation of their porosity,
the aim of future studies will be to assess that the
mechanical properties of the scaffolds are suitable for
bone applications.17–19
Experimental
Glass powder mixtures
Preparation of glass powder mixtures
ICEL (molar composition 45% P2O5, 3% SiO2,
26% CaO, 7% MgO, 15% Na2O, 4% K2O) and CEL2
(molar composition 45% SiO2, 3% P2O5, 26% CaO,
7% MgO, 15% Na2O, 4% K2O) glasses were prepared by
the melt quenching process. ICEL precursors
[(NH4)2HPO4, SiO2, Ca3(PO4)2, Na3PO4.12H2O,
Mg3(PO4)2.8H2O, K2HPO4] were placed into a Pt/Rh
crucible for melting at 1200uC in air for 1 h (heating rate
10uC min21) and poured on a brass plate. The
precursors of CEL2 [SiO2, Ca3(PO4)2, CaCO3,
(MgCO3)4.Mg(OH)2.5H2O, Na2CO3, K2CO3] were placed
into aPt crucible formelting at 1500uC inair for 1 h (heating
rate 10uC min21) and then quenched into cold water.
The glasses were then ball milled and sieved (v32 mm).
ICEL and CEL2 powders were mixed in different
ratios (wt-%: 100%ICEL, 70%ICEL–30%CEL2,
30%ICEL–70%CEL2, 100%CEL2; codes 100-0, 70-30,
30-70, 0-100 respectively) as reported in Table 1. It was
not possible to obtain a good sintering of a mixture of
50%ICEL–50%CEL2 (wt-%), and for this reason, this
glass ratio has not been further investigated.
Differential thermal analysis and hot stage
microscopy
Differential thermal analysis (DTA; Netzsch DTA
404 PC) was carried out on the different glass mixtures
(heating rate 10uC min21), and the glass transition (Tg),
the onset crystallisation (Tx) and the peak crystallisation
(Tc) temperatures were determined. Hot stage
microscopy (HSM; Misura, Expert System Solutions,
Modena, Italy) was carried out (air atmosphere, heating
rate 10uC min21) in order to study the sintering process
of the different glass powder mixtures (cylinder of
pressed glass powder, diameter 1 mm, height 3 mm).
HSM software automatically reports the height %
(i.e. percentage of the sample height referred to the in-
itial sample height) at the investigated temperatures and
the melting point (i.e. temperature at which the height of
the samples shrinks to under a third of the base). The
melting temperature (Tm) was determined by the infor-
mation obtained by both HSM and DTA results.
Scaffold preparation
Gel cast foaming
The scaffolds were prepared using the gel cast foaming
method15,16 combined with freeze drying (Fig. 1).
Gelatin from porcine skin (Sigma-Aldrich) was dissolved
in bidistilled water at 40uC under magnetic stirring to
obtain a 50 mg ml21 gelatin/water solution. The glass
powder (1.25 g ml21) and the surfactant (2%, v/v, Triton
X-100, Sigma-Aldrich) were then added into the sol-
ution. A vigorous agitation was carried out in order to
induce the foaming of the suspension. The obtained
porous structure was then stabilised through the gelatin
gelation in an ice bath, before the freeze drying process.
A thermal treatment was then carried out in order to
remove the gelatin and to sinter the glass powder
mixture.
Sintering and porosity optimisation
On the basis of the results of DTA and HSM results,
sintering treatments at different temperatures were car-
ried out on samples of the lyophilised glass/gelatin
porous materials (10|5|5 mm) placed on a Pt lid
(1 h, heating rate 10uC min21) to thermally remove the
gelatin and to sinter the glass powder. The sintering
treatment was optimised in order to obtain both a
satisfactory densification and a high scaffold porosity.
Scaffold characterisation
Microcomputed tomography and field emission scanning
electron microscopy
The samples were analysed with microcomputed tom-
ography (micro-CT, Skyscan 1174, Bruker) after the
thermal treatment. Using the CTAn software, after the
segmentation of the images, a 3-D morphometric
analysis was carried out to evaluate the scaffold total
and open porosity percentage. The more promising
scaffolds in term of morphological features were then
analysed with field emission scanning electron
microscopy (FESEM; SUPRATM 40, Zeiss) to assess
the quality of the sintering. Combining the results of
micro-CT and FESEM analysis, the appropriate
sintering temperatures for the different glass powder
mixtures were selected.
X-ray diffraction analysis
Scaffolds obtained using the optimised sintering con-
ditions were ground and then crushed powders were
studied by X-ray diffraction (XRD) analysis (X’Pert
diffractometer, Bragg–Brentano camera geometry with
Cu Ka incident radiation) to assess the formation of
crystalline phases upon the thermal treatment.
Bioactivity and dissolution test
Three samples of each scaffold type (5|5|5 mm3)
obtained using the optimised sintering conditions
were soaked in 20 ml of simulated body fluid (SBF)
and stored in an incubator at 37uC (refresh of the
Table 1 Amount of ICEL and CEL2 glasses in different glass
powder mixtures
Glass powder mixture code ICEL wt-% CEL2 wt-%
100-0 (ICEL) 100 0
70-30 70 30
30-70 30 70
0-100 (CEL2) 0 100
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SBF twice a week). After 4 weeks of soaking, the scaf-
folds were washed with bidistilled water, dried at room
temperature and weighted. The mass loss of the samples
was calculated as follows:
100 £ m2m0
m0
 
ð1Þ
where m is the sample mass after 4 weeks of soaking in
SBF and m0 is the sample initial mass.
FESEM analysis was carried out on the scaffolds after
4 weeks of soaking in SBF to assess the nucleation of
HCA on the scaffolds.
In vitro test
In vitro cell culture tests with human osteosarcoma
(HOS; CRL 1543) osteoblasts (5|105 cells, 3 ml
medium, refresh every 2 days) were performed on
5|5|2 mm3 scaffolds obtained using the optimised
sintering conditions to investigate the in vitro bio-
compatibility. The cells were cultured in DMEM
(1 g L21 glucose) with 10% fetal calf serum and
1% antibiotics in an incubator, at 37uC with 5% CO2.
Cells (500|103) were seeded on the upper surface of
each scaffold with 3 ml of medium. The medium was
refreshed every 48 h. At different incubation time points
(2, 5, 7, 14 and 21 days), the scaffolds were removed
from the medium and washed in phosphate buffered
saline (PBS) solution; then, they underwent eosin or
fluorescence (DAPI/Vybrant) staining for cell
observation using a light and fluorescence microscope.20
Results and discussion
DTA and HSM
The graphs related to DTA and HSM analysis for the
different glass powder mixtures are reported in Fig. 2,
while the obtained characteristic temperatures are sum-
marised in Table 2.
For what concern the DTA results, as expected, the
characteristic temperatures found for 100-0 (ICEL
phosphate glass) (Fig. 2a1) were lower than those of
0-100 (CEL2 silicate glass) (Fig. 2d1). Both glass mix-
tures 70-30 and 30-70 showed Tg (418 and 421uC
respectively) close to that of ICEL (Tg 410uC). These
low Tg can be explained considering that, during the
heating of the glass mixtures, ICEL glass is the first one
that undergoes the glass transition process, while CEL2
has not reached it yet. The Tx for 70-30 and 30-70
(*535uC) were lower than those of ICEL glass (568uC)
and were close to the Tg of CEL2 glass (529uC). It can
be supposed that when CEL2 reaches its Tg, ion dif-
fusion between the CEL2 and ICEL powders occurs,
leading to a change in the composition of the glasses.
In fact, co-sintering of glasses with different compo-
sitions usually represents a system showing unlimited
mutual solubility, which contains, at intermediate
stages, the initial glasses and a solid solution of vari-
able concentration.21 This can lead to a change of the
nucleation temperatures of the crystalline phases or
even the nucleation of crystalline phases different from
those that would nucleate in the two glasses alone (see
the ‘XRD analysis’ section).
When considering the 100-0 sample (ICEL glass)
HSM curve (Fig. 2a2), the shrinkage of the sample
started at 420uC, just above Tg (406uC), due to viscous
flow, stopping at*560uC. In fact, a remarkable increase
of the viscosity occurred during crystallisation (Tx
568uC) and this is likely to inhibit viscous flow sinter-
ing.22 For 100-0, the final shrinkage at the end of to the
densification process was *45% and Tm was 660uC,
according to the melting point found by HSM (see HSM
picture in Fig. 2a2) and DTA analysis.
For 70-30, HSM results (Fig. 2b2) show that the
shrinkage of the samples took place from 460uC,*40uC
above theTg (418uC); thus, the presence ofCEL2 caused
a delay in the sample shrinkage if compared to ICEL.
Moreover, the sample showed a significantly lower
shrinkage (&6%) at the end of the first densification step
if compared to ICEL at the same temperature (&35%);
Table 2 Characteristic temperatures of glass powder
mixtures
Glass powder mixture code Tg/8C Tx/8C Tc/8C
100-0 (ICEL) 408 568 612
70-30 418 537 559
764 821
30-70 421 532 563
762 842
0-100 (CEL2) 529 662 698;742
870 1014
1 Scheme of scaffold preparation
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this is realistic since this densification step can be
ascribed mainly to the viscous flow of the 70% of ICEL
in 70-30, as CEL2 is still below its Tg. The densification
stopped at *530uC, when the crystallisation process
occurs (Tx 537uC). A further increase in the temperature
led to a decrease in the viscosity, leading to a second
densification step at*800uC (&32% of shrinkage), and
a melting point at 1000uC was found. After melting,
70-30 showed a slightly irregular shape (see HSM
picture in Fig. 2b2) if compared to the typical rounded
shape found for the other samples. This aspect could be
due to a second crystallisation of 70-30 at*820uC.
A different behaviour was found for 30-70 analysed
by HSM (Fig. 2c2) as the sample shrinkage began
at *1050uC, a significantly higher temperature
compared to the Tg (421uC). In fact, the Tg in the 30-70
mixture (30 wt-% ICEL–70 wt-% CEL2) is due to the
presence of ICEL glass, which, however, is not the main
component of the mixture. Densification did not
occur even above 530uC, which is the Tg of CEL2,
the main component of the mixture (see Fig. 2d1).
Since crystallisation began above this temperature
(Tx 532uC and 762uC), it can be supposed that the densi-
fication and viscous flow of the glass powder is hindered
by the viscosity increase associated to crystallisation.
Finally, the increase of the temperature led to a decrease
of the viscosity andadensificationof the samples occurred
above 1050uC (&18 shrinkage %). HSM analysis indi-
cated the melting point of the sample at 1110uC.
As regard HSM result for 0-100 (CEL2 glass)
(Fig. 2d2), a shrinkage of the sample occurred just after
Tg (529uC) and continued until the crystallisation took
place (662uC), reaching a final shrinkage of 34% at the
end of the densification process. The sample showed a
final expansion step (w960uC), probably related to a
second crystallisation process in which the increase in
volume was not balanced by shrinkage since full densi-
fication was already complete; this behaviour is in
accordance to a previous study.22 Melting temperature
of this sample was *1100uC, according to both HSM
results (melting point at 1085uC, see HSM picture in
Fig. 2d2) and DTA melting peak at 1100uC.
2 Graphs of thermal analysis on ICEL glass (a1, DTA; a2, HSM), on 30-70 glass mixture (b1, DTA; b2, HSM), on 70-30 glass
mixture (c1, DTA; c2, HSM) and on CEL2 glass (d1, DTA; d2, HSM); HSM results show both height % curve and sample
picture at melting temperature individuated by HSM software (i.e. temperature at which height of samples shrinks to under
third of the base)
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3 Summary of the results of sintering trials for different glass powder mixtures: a all sintering trials reported on HSM curves
and example of 3-D model of scaffold obtained from micro-CT results using CTvox software (white lines in three directions
correspond to 1 mm); examples of sections of scaffolds derived by micro-CT analysis and FESEM images: 100-0 (ICEL)
scaffold sintered at 6108C: section of scaffold derived by bmicro-CT analysis (porosity 62 vol.-%) and c FESEM micrograph;
70-30 scaffold sintered at 7008C: section of scaffold derived by d micro-CT analysis (porosity 75 vol.-%) and e FESEM
micrograph; section derived by micro-CT analysis of 70-30 scaffolds sintered at f 7508C and g 11008C, both showing collapse
of scaffold structure and very low porosity (,25 vol.-%); 30-70 scaffold sintered at 10008C: section of scaffold derived by h
micro-CT analysis (porosity 69 vol.-%) and i FESEM micrograph, showing poor sintering quality; 30-70 scaffold sintered at
11008C: section of scaffold derived by l micro-CT analysis (porosity 55 vol.-%) and m FESEM micrograph; n section derived
by micro-CT analysis of 30-70 scaffolds sintered at 12508C, which shows collapse of scaffold structure and very low porosity
(14 vol.-%); 0-100 (CEL2) scaffold sintered at 6108C: section of scaffold derived by o micro-CT analysis (porosity 56 vol.-%)
and p FESEM micrograph, showing poor sintering quality; 0-100 (CEL2) scaffold sintered at 6408C: section of scaffold
derived by q micro-CT analysis (porosity 47 vol.-%) and r FESEM micrograph; s section derived by micro-CT analysis of
0-100 (CEL2) scaffolds sintered at 9508C (porosity 40 vol.-%)
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Sintering and porosity optimisation
Different thermal treatments were performed in order
to optimise the temperature and times that would
allow a proper balance between a satisfactory
densification and high scaffold porosity. The total and
open porosity percentages of the scaffolds were measured
using 3-D morphometric analyses carried out after
segmentation of the micro-CT images, while the scaffold
sintering quality was investigated using FESEM.
Figure 3a summarises the sintering treatments that
were carried out and reports an example of a 3-D model
of the scaffold obtained from micro-CT analysis using
CTvox software.
As regard pure ICEL and CEL2 compositions, the
first sintering treatment was carried out with the con-
ditions previously optimised for the preparation of glass
ceramic scaffolds by the sponge replication method,
which are 610uC6,9 and 950uC10 respectively.
As regard 100-0 (ICEL) scaffold, it was possible to
obtain high porosity (62 vol.-%, completely inter-
connected) with a thermal treatment at 610uC (Fig. 3b
and c), and thus, no further thermal treatments were
carried out.
For 70-30, thermal treatments at 1100uC (Fig. 3g),
1080uC, 920uC, 800uC and 750uC (Fig. 3f ) were tested,
but they all produced a collapse of the scaffold structure
(porosity v25 vol.-%). Finally, at 700uC, a porosity of
75 vol.-%, completely interconnected and a good strut
densification were obtained (Fig. 3d and e).
For 30-70, a thermal treatment at 1250uC (Fig. 3n)
resulted in a collapse of the scaffold (porosity 14 vol.-%),
while a treatment at 1220uC produced a well sintered
structure with a porosity of 45 vol.-%. To further increase
the porosity of the scaffold, lower temperatures were also
tested. No sintering was achieved at 950uC, while a treat-
ment at 1000uCresulted in scaffoldswith an interconnected
porosity of 69 vol.-%, but the degree of sintering was not
optimal, as assessed with FESEM analysis (Fig. 3h and i).
Finally, thermal treatment at 1100uC resulted in a well
sintered scaffold with a porosity of 55 vol.-%, completely
interconnected (Fig. 3l and m).
With regard to 0-100 (CEL2), sintering of the scaffold
was obtained at 950uC with an interconnected porosity
of 40 vol.-% (Fig. 3s); to increase the porosity, treat-
ments at lower temperatures (900, 800 and 700uC) were
performed, obtaining similar results. By further
decreasing the temperature to 550uC, no sintering was
achieved. A treatment at 610uC resulted in a porosity of
56 vol.-%; however, FESEM analysis showed that the
sintering quality was not satisfactory (Fig. 3o and p).
A further trial at 640uC resulted in a well sintered
scaffold with a porosity of 47 vol.-% (Fig. 3q and r),
and thus, this temperature was chosen as the
optimal one.
At the end of this optimisation phase, the selected
sintering temperatures were 610uC for 100-0 (ICEL),
700uC for 70-30, 1100uC for 30-70 and 640uC for 0-100
(CEL2). Scaffold total porosity was 62, 75, 51 and
47 vol.-%, completely interconnected, and the mean pore
size was 170, 216, 118 and 185 mm respectively for 100-0
(ICEL), 70-30, 30-70 and 0-100 (CEL2) scaffold. All the
scaffolds showed pore sizes ranging from 10 to 400–
500 mm. In view of in vivo application, the obtained
scaffold structure meets the requirements needed for
both cell migration and new vessel formation.
XRD analysis
XRD spectra of the different scaffolds obtained using
the optimised sintering conditions [i.e. 610uC for 100-0
(ICEL), 700uC for 70-30, 1100uC for 30-70 and 640uC
for 0-100 (CEL2); 1 h at 10uC min21] are reported in
Fig. 4. The co-sintering of different glasses (70-30 and
30-70 samples) resulted in the formation of crystalline
phases (Ca2P2O7 for 70-30 and NaCaPO4 for 30-70)
different from that found for the as such glasses
ICEL [Ca2P2O7 and Na4Ca(PO3)6] and CEL2 [Na4-
Ca4(Si6O18)]. The nucleation of these new phases was
attributed to diffusion phenomena between the two
glasses, leading to compositional changes in the ma-
terials and influencing the nucleation and growth of the
crystalline phases. As expected, the presence of the ICEL
phosphate glass in the initial glass powder mixture had
favoured the nucleation of phosphate crystalline phases
over silicate phases during the sintering process, the
latter being present only for the scaffold obtained from
pure CEL2 powder.
4 XRD patterns of powders from ground scaffolds: a 100-0 (ICEL) scaffold sintered at 6108C (1 h); b 70-30 scaffold sintered at
7008C (1 h); c 30-70 scaffold sintered at 11008C (1 h); d 0-100 (CEL2) scaffold sintered at 6408C (1 h)
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In a previous work, CEL2 scaffolds obtained by the
foam replication technique were sintered at 950uC and
showed the nucleation of two crystalline phases
[i.e. Na4Ca4(Si6O18) and Ca2Mg(Si2O7)].
23 With the gel
cast foaming method used here, it was possible to attain
CEL2 scaffold sintering at much lower temperature
(640uC), which resulted in the formation of the sole
Na4Ca4(Si6O18).
Bioactivity and dissolution test
The mass loss of the scaffolds obtained with the opti-
mised sintering conditions after 4 weeks of soaking in
SBF is reported in Table 3. As expected, increasing
content of ICEL phosphate glass resulted in a rise of the
mass loss of the scaffolds.
The pH of the solution did not show significant
changes during scaffold soaking, remaining in the
physiological range (data not shown).
FESEM images on the scaffold surface and energy
dispersive spectroscopy analysis (Ca/P&1,67) confirmed
Table 3 Mass loss of different scaffolds after 4 weeks of
soaking in SBF
Scaffold code % Mass loss
100-0 (ICEL) 51¡3
70-30 31¡2
30-70 10¡1
0-100 (CEL2) 15¡2
5 FESEM images showing hydroxyapatite (HA) on trabeculae surface of a, b 30-70 and c, d CEL2 scaffolds after 4 weeks in
SBF
6 HOS osteoblast cells on CEL2 scaffold after 2 days of incubation: images of a fluorescence microscope (DAPI/Vybrant
fluorescent dyes) and b light microscope (eosin staining), showing cells both on surface and inside scaffold pores (arrows);
both stainings, fluorescence and eosin staining, revealed good osteoblastic cell attachment and development
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the presence of HCA on 30-70 (Fig. 5a and b) and 0-100
(CEL2) scaffolds (Fig. 5c and d). The bioactivity of CEL2
glass–ceramic scaffold was already assessed in previous
studies.9,10 As regard 30-70, the high bioactivity can be due
to the presence of b-NaCaPO4 (b-rhenanite), which is
known to react with water to transform into HCA, thus
being a nucleation precursor for HCA formation.24,25
In vitro test
The evaluation of the cell morphology on all the scaffolds
obtained with the optimised sintering conditions after
2 days of incubationwithHOSosteoblasts cells showed the
presence of the cells not only on the surface but also inside
the pores of the different scaffolds. The fluorescence aswell
as the eosin staining revealed good cell attachment and
development. In Fig. 6a and b, representative examples of
the results forCEL2 scaffoldare reported.The same results
were found at the different time points. This preliminary
in vitro test indicated that all the scaffolds showed no toxic
effect on cells.
Conclusions
Porous 3-D glass–ceramic scaffolds were successfully
obtained using the gel cast foaming methods by
co-sintering a mixture of ICEL (phosphate glass) and
CEL2 (silicate glass) in different ratios. The optimisation
of the sintering conditions allowed the obtainment of
scaffolds that fulfill the needed requirements in term of
interconnected porosity, ranging between 47 and 75
vol.-% and pore size up to *500 mm. Moreover, the
co-sintering of ICEL and CEL2 glasses in different
ratios was effective for tailoring the dissolution rate of
the scaffolds, which increased with ICEL glass content.
Scaffolds containing higher CEL2 amount showed to be
bioactive, inducing the nucleation of HCA on their
surface in SBF. The scaffolds did not induce any toxic
effect on cells. A mechanical characterisation and pro-
longed and more detailed study on the scaffold bioac-
tivity and dissolution need to be carried out in order to
better investigate the potential of these novel scaffolds
for bone applications. From the results of the present
study, it is possible to conclude that the combination of
a phosphate and silicate glass proved to be an effective
strategy to tailor the dissolution kinetics and bioactivity
of the scaffold with the aim of matching the desired
properties required for the specific clinical application.
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